These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 31018579)
21. ESPERANTO: a GLP-field sEmi-SuPERvised toxicogenomics metadAta curatioN TOol. Di Lieto E; Serra A; Inkala SI; Saarimäki LA; Del Giudice G; Fratello M; Hautanen V; Annala M; Federico A; Greco D Bioinformatics; 2023 Jun; 39(6):. PubMed ID: 37354497 [TBL] [Abstract][Full Text] [Related]
22. Challenges for FAIR-compliant description and comparison of crop phenotype data with standardized controlled vocabularies. Andrés-Hernández L; Halimi RA; Mauleon R; Mayes S; Baten A; King GJ Database (Oxford); 2021 May; 2021():. PubMed ID: 33991093 [TBL] [Abstract][Full Text] [Related]
23. NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases. Bagewadi S; Adhikari S; Dhrangadhariya A; Irin AK; Ebeling C; Namasivayam AA; Page M; Hofmann-Apitius M; Senger P Database (Oxford); 2015; 2015():. PubMed ID: 26475471 [TBL] [Abstract][Full Text] [Related]
24. The center for expanded data annotation and retrieval. Musen MA; Bean CA; Cheung KH; Dumontier M; Durante KA; Gevaert O; Gonzalez-Beltran A; Khatri P; Kleinstein SH; O'Connor MJ; Pouliot Y; Rocca-Serra P; Sansone SA; Wiser JA; J Am Med Inform Assoc; 2015 Nov; 22(6):1148-52. PubMed ID: 26112029 [TBL] [Abstract][Full Text] [Related]
25. Leveraging heterogeneous data from GHS toxicity annotations, molecular and protein target descriptors and Tox21 assay readouts to predict and rationalise acute toxicity. Allen CHG; Mervin LH; Mahmoud SY; Bender A J Cheminform; 2019 May; 11(1):36. PubMed ID: 31152262 [TBL] [Abstract][Full Text] [Related]
26. Tyto: A Python Tool Enabling Better Annotation Practices for Synthetic Biology Data-Sharing. Bartley BA ACS Synth Biol; 2022 Mar; 11(3):1373-1376. PubMed ID: 35226470 [TBL] [Abstract][Full Text] [Related]
28. Curating and Preparing High-Throughput Screening Data for Quantitative Structure-Activity Relationship Modeling. Kim MT; Wang W; Sedykh A; Zhu H Methods Mol Biol; 2016; 1473():161-72. PubMed ID: 27518634 [TBL] [Abstract][Full Text] [Related]
29. Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays. Ngan DK; Ye L; Wu L; Xia M; Rossoshek A; Simeonov A; Huang R Front Big Data; 2019; 2():50. PubMed ID: 33693373 [TBL] [Abstract][Full Text] [Related]
30. Community standards for open cell migration data. Gonzalez-Beltran AN; Masuzzo P; Ampe C; Bakker GJ; Besson S; Eibl RH; Friedl P; Gunzer M; Kittisopikul M; Dévédec SEL; Leo S; Moore J; Paran Y; Prilusky J; Rocca-Serra P; Roudot P; Schuster M; Sergeant G; Strömblad S; Swedlow JR; van Erp M; Van Troys M; Zaritsky A; Sansone SA; Martens L Gigascience; 2020 May; 9(5):. PubMed ID: 32396199 [TBL] [Abstract][Full Text] [Related]
32. Prediction of chemical-induced acute toxicity using in vitro assay data and chemical structure. Luo X; Xu T; Ngan DK; Xia M; Zhao J; Sakamuru S; Simeonov A; Huang R Toxicol Appl Pharmacol; 2024 Nov; 492():117098. PubMed ID: 39251042 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity Burst? Differentiating Specific from Nonspecific Effects in Tox21 Escher BI; Henneberger L; König M; Schlichting R; Fischer FC Environ Health Perspect; 2020 Jul; 128(7):77007. PubMed ID: 32700975 [TBL] [Abstract][Full Text] [Related]
35. The US Federal Tox21 Program: A strategic and operational plan for continued leadership. Thomas RS; Paules RS; Simeonov A; Fitzpatrick SC; Crofton KM; Casey WM; Mendrick DL ALTEX; 2018; 35(2):163-168. PubMed ID: 29529324 [TBL] [Abstract][Full Text] [Related]
36. High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions. Lynch C; Sakamuru S; Ooka M; Huang R; Klumpp-Thomas C; Shinn P; Gerhold D; Rossoshek A; Michael S; Casey W; Santillo MF; Fitzpatrick S; Thomas RS; Simeonov A; Xia M Annu Rev Pharmacol Toxicol; 2024 Jan; 64():191-209. PubMed ID: 37506331 [TBL] [Abstract][Full Text] [Related]
37. Assessing Public Metabolomics Metadata, Towards Improving Quality. Ferreira JD; Inácio B; Salek RM; Couto FM J Integr Bioinform; 2017 Dec; 14(4):. PubMed ID: 29236679 [TBL] [Abstract][Full Text] [Related]
38. Tox21-Based Comparative Analyses for the Identification of Potential Toxic Effects of Environmental Pollutants. Yang R; Liu S; Yin N; Zhang Y; Faiola F Environ Sci Technol; 2022 Oct; 56(20):14668-14679. PubMed ID: 36178254 [TBL] [Abstract][Full Text] [Related]
39. Recent developments in in vitro toxicology: perspectives of European research and Tox21. Marchan R; van Thriel C; Bolt HM Arch Toxicol; 2013 Dec; 87(12):2043-6. PubMed ID: 24221536 [No Abstract] [Full Text] [Related]
40. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Fielden MR; Zacharewski TR Toxicol Sci; 2001 Mar; 60(1):6-10. PubMed ID: 11222867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]